Organization
Kyoto University, Graduate School of Medicine
3 clinical trials
Clinical trial
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 StudyStatus: Active (not recruiting), Estimated PCD: 2018-12-08
Clinical trial
Study to Evaluate the Safety of Reducing Dual Antiplatelet Therapy (DAPT) Duration to 1 Month for Patients With Acute Coronary Syndrome (ACS) After Implantation of Everolimus-eluting Cobalt-chromium StentStatus: Active (not recruiting), Estimated PCD: 2021-12-31
Clinical trial
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy Study After Everolimus-eluting Cobalt-chromium Stent-3Status: Active (not recruiting), Estimated PCD: 2023-12-31